Last reviewed · How we verify
Omega-3 Lipid Emulsion
Omega-3 Lipid Emulsion is a Small molecule drug developed by Fujian Medical University. It is currently in Phase 1 development. Also known as: ω-3 Lipid Emulsion, Omega-3 PUFA, Omega-3 Fatty Acid Emulsion.
At a glance
| Generic name | Omega-3 Lipid Emulsion |
|---|---|
| Also known as | ω-3 Lipid Emulsion, Omega-3 PUFA, Omega-3 Fatty Acid Emulsion |
| Sponsor | Fujian Medical University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Alanine Aminotransferase increased
- Diarrhoea
- White blood cell
- Overdose
- Breast abscess
- Nausea
- Muscle spasms
- Palpitations
- Headache
- Hyperhydrosis
- Anaemia
- Hypophosphataemia
Key clinical trials
- Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH (PHASE2)
- Preoperative Fish Oil PN and Prognosis After Constipation Surgery
- Reprometabolic Syndrome Mediates Subfertility in Obesity (NA)
- Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients (PHASE2)
- Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation. (PHASE1, PHASE2)
- Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure (NA)
- Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication (NA)
- The HOME Study (HPN With OMEGA-3) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Omega-3 Lipid Emulsion CI brief — competitive landscape report
- Omega-3 Lipid Emulsion updates RSS · CI watch RSS
- Fujian Medical University portfolio CI
Frequently asked questions about Omega-3 Lipid Emulsion
What is Omega-3 Lipid Emulsion?
Omega-3 Lipid Emulsion is a Small molecule drug developed by Fujian Medical University.
Who makes Omega-3 Lipid Emulsion?
Omega-3 Lipid Emulsion is developed by Fujian Medical University (see full Fujian Medical University pipeline at /company/fujian-medical-university).
Is Omega-3 Lipid Emulsion also known as anything else?
Omega-3 Lipid Emulsion is also known as ω-3 Lipid Emulsion, Omega-3 PUFA, Omega-3 Fatty Acid Emulsion.
What development phase is Omega-3 Lipid Emulsion in?
Omega-3 Lipid Emulsion is in Phase 1.
What are the side effects of Omega-3 Lipid Emulsion?
Common side effects of Omega-3 Lipid Emulsion include Alanine Aminotransferase increased, Diarrhoea, White blood cell, Overdose, Breast abscess, Nausea.
Related
- Manufacturer: Fujian Medical University — full pipeline
- Also known as: ω-3 Lipid Emulsion, Omega-3 PUFA, Omega-3 Fatty Acid Emulsion
- Compare: Omega-3 Lipid Emulsion vs similar drugs
- Pricing: Omega-3 Lipid Emulsion cost, discount & access